The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford regional prospective study

Kidney International

Volumn 68, Issue 4, 2005, Pages 1740-1749

  Amin, Rakesh ^b   Turner, Charles ^b   Van Aken, Sara ^b   Bahu, Teresa Konopelska ^b   Watts, Angela ^b   Lindsell, David R M ^b   Dalton, R Neil ^b   Dunger, David B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Blood pressure; GFR; HbA1c; Hyperfiltration; Microalbuminuria; Puberty

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CHILD; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROALBUMINURIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; RISK ASSESSMENT; STATISTICAL ANALYSIS; ULTRAFILTRATION;

ADOLESCENT; ALBUMINURIA; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; KIDNEY; LONGITUDINAL STUDIES; MALE; PREVALENCE; PROSPECTIVE STUDIES; PUBERTY; RISK FACTORS;

EID: 29644435379     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00590.x     Document Type: Article

References (52)

1. BRENNER BM, MEYER TW, HOSTETTER TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
2. HOSTETTER TH, OLSON JL, RENNKE HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-93, 1981
3. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
4. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
5. MYERS BD, DEEN WM, BRENNER BM: Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101-110, 1975
6. RUGIU C, OLDRIZZI L, LUPO A, et al: Clinical features of patients with solitary kidneys. Nephron 43:10-15, 1986
7. BRENNER BM, CHERTOW GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
8. SOLOMON LR, MALLICK NP, LAWLER W: Progressive renal failure in a remnant kidney. Br Med J (Clin Res Ed) 291:1610-1611, 1985
9. ZATZ R, MEYER TW, RENNKE HG, BRENNER BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82:5963-5967, 1985
10. ZATZ R, DUNN BR, MEYER TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
11. MOGENSEN CE, ANDERSEN MJ: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706-712, 1973
12. CHRISTIANSEN JS, GAMMELGAARD J, FRANDSEN M, PARVING HH: Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 20:451-456, 1981
13. MOGENSEN CE, CHRISTENSEN CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
14. MOGENSEN CE: Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46:201-206, 1986
15. DAHLQUIST G, APERIA A, BROBERGER O, et al: Renal function in relation to metabolic control in children with diabetes of different duration. Acta Paediatr Scand 72:903-909, 1983
16. RUDBERG S, PERSSON B, DAHLQUIST G: Increased glomerular filtration rate as a predictor of diabetic nephropathy - An 8-year prospective study. Kidney Int 41:822-828, 1992
17. CHIARELLI F, VERROTTI A, MORGESE G: Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 9:154-158, 1995
18. LERVANG HH, JENSEN S, BROCHNER-MORTENSEN J, DITZEL J: Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Diabet Med 9:635-640, 1992
19. YIP JW, JONES SL, WISEMAN MJ, et al: Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 45:1729-1733, 1996
20. PERKINS BA, FICOCIELLO LH, SILVA KH, et al: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293, 2003
21. SCHULTZ CJ, KONOPELSKA-BAHU T, DALTON RN, et al: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495-502., 1999
22. DAVIS JE, MCDONALD JM, JARETT L: A high-performance liquid chromatography method for hemoglobin A1c. Diabetes 27:102-107., 1978
23. DINKEL E, ERTEL M, DITTRICH M, et al: Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 15:38-43, 1985
24. MONTINI G: The estimation of glomerular filtration rate from a single injection plasma inulin measurements using numerical analysis. Pediatr Nephrol 3:C128, 1989
25. DALTON RN, TURNER C: A sensitive and specific method for the measurement of inulin. Ann Clin Biochem 24(Suppl 1):S1-231, 1987
26. VEALL N, GIBBS GP: The accurate determination of tracer clearance rates and equilibrium distribution volumes from single injection plasma measurements and numerical analysis. Radionuclides in Nephrology, Proceedings of the 5th Symposium, London, 1982
27. 51Cr-EDTA. Clin Sci 37:169-180, 1969
28. COLE TJ, FREEMAN JV, PREECE MA: British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 17:407-429, 1998
29. SCHULTZ CJ, NEIL HA, DALTON RN, DUNGER DB: Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care 23:1811-1815, 2000
30. BERG UB, TORBJORNSDOTTER TB, JAREMKO G, THALME B: Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 41:1047-1056, 1998
31. RUDBERG S, OSTERBY R, DAHLQUIST G, et al: Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 20:265-271, 1997
32. CARAMORI ML, FIORETTO P, MAUER M: Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes 52:1036-1040, 2003
33. BANGSTAD HJ, OSTERBY R, HARTMANN A, et al: Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria. Diabetes Care 22:314-319, 1999
34. BANGSTAD HJ, OSTERBY R, DAHL-JORGENSEN K, et al: Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:523-529, 1993
35. DAHLQUIST G, STATTIN EL, RUDBERG S: Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy: A long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant 16:1382-1386, 2001
36. REMUZZI A, VIBERTI G, RUGGENENTI P, et al: Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol 259:F545-552, 1990
37. BANGSTAD HJ, OSTERBY R, RUDBERG S, et al: Kidney function and glomerulopathy over 8 years in young patients with type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 45:253-261, 2002
38. MOGENSEN CE, CHRISTENSEN CK, PEDERSEN MM, et al: Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabet Complications 4:159-165, 1990
39. THOMSON SC, DENG A, BAO D, et al: Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107:217-224, 2001
40. O'HAGAN M, HOWEY J, GREENE SA: Increased proximal tubular reabsorption of sodium in childhood diabetes mellitus. Diabet Med 8:44-48, 1991
41. EDGE JA, DUNGER DB, MATTHEWS DR, et al: Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71:1356-1362, 1990
42. FLYVBJERG A: Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43:1205-1223, 2000
43. DOI T, STRIKER LJ, GIBSON CC, et al: Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 137:541-552, 1990
44. SEGEV Y, LANDAU D, RASCH R, et al: Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice. J Am Soc Nephrol 10:2374-2381, 1999
45. AMIN R, SCHULTZ C, ONG K, et al: Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: The Oxford Regional Prospective Study. Diabetes Care 26:1456-1461, 2003
46. AMIN R, WILLIAMS RM, FRYSTYK J, et al: Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: The Oxford Regional Prospective Study. Clin Endocrinol (Oxf) 62:137-144, 2005
47. SCHULTZ CJ, NEIL HA, DALTON RN, et al: Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 24:555-560, 2001
48. TAAL MW, BRENNER BM: Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int 57:1803-1817, 2000
49. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
50. LEWIS EJ, HUNSICKER LG, CLARKE WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
51. BRENNER BM, COOPER ME, DE ZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
52. RUDBERG S, RASMUSSEN LM, BANGSTAD HJ, OSTERBY R: Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care 23:544-548, 2000